Zadnji put ažurirano :
19/11/2024
lijek protiv karcinoma   Mitomycin  
injekcija
Stabilizacija rješenja Stabilnost mješavine Stabilizacijski faktor Kompatibilnosti način davanja lijeka Bibliografija pdf
   Kemijska struktura  

Nekomercijalni   Nekomercijalni     

Zaštićeni nazivi su indikativni i sastav ekscipijensa može biti različit ovisno o državi i laboratorijima

Ametycine Francuska
Crisofimina Argentina
Fatrix Čile
Maximitom Argentina
Maximiton Ekvador
Minazol Kolumbija
Mitameta Italija
Mitem Njemačka, Švicarska
Mitocin Brazil
Mitokebir Argentina, Ekvador
Mitolem Kolumbija, Venecuela
Mitomicina Argentina, Čile, Ekvador, Italija, Meksiko, Peru, Portugal, Rumunjska, Španjolska
Mitomycin Austrija, Belgija, Danska, Finska, Grčka, Iran, Irska, Italija, Madžarska, Malezija, Njemačka, Norveška, novi Zeland, Poljska, S A D, Slovenija, Švedska, Turska, Velika Britanija
Mitomycine Luksemburg, Nizozemska
Mitotie Argentina, Čile, Ekvador, Peru
Mitozytrex S A D
Mixandex Kolumbija, Meksiko
Mutamycin S A D
Riptam Kolumbija
Ronzine Argentina, Peru
Urocin Njemačka
Bibliografija   injekcija   Bibliografija : Mitomycin  
Vrsta Publikacija
3 Časopis Trissel LA, Martinez JF.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
81 Časopis Trissel LA, Martinez JF.
Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 672-678.
84 Časopis Trissel LA, Martinez JF.
Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 495-499.
99 Časopis Trissel LA, Martinez JF.
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
169 Časopis Trissel LA, Martinez JF.
Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1993 ; 50: 2359-2363.
182 Časopis Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60.
244 Časopis Trissel LA, Martinez JF.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1907-1913.
249 Časopis Trissel LA, Martinez JF.
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
307 Časopis Trissel LA, Martinez JF.
Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1792-1799.
334 Časopis Trissel LA, Tramonte SM, Grilley BJ.
Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 988-992.
335 Časopis Trissel LA, Bready BB, Kwan JW, Santiago NM.
Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 402-406.
407 Časopis Quebberman EJ, Hoffman NE, Ausman RK, Hamid AAR.
Stability of mitomycin admixtures.
Am J Hosp Pharm 1985 ; 42: 1750-1754.
485 Časopis Dorr RT, Liddil JD.
Stability of mitomycin C in different infusion fluids: compatibility with heparin and glucocorticosteroids.
J Oncol Pharm Practice 1995 ; 1: 19-24.
648 Časopis Das Gupta V.
Stability of mitomycin aqueous solution when stored in tuberculin syringes.
Int J Pharm Compound 1997 ; 1: 282-283.
835 Časopis Edwards D, Selkirk AB, Taylor RB.
Determination of the stability of mitomycin C by high performance liquid chromatography.
Int J Pharm 1979 ; 4: 21-26.
905 Časopis Trissel LA, Martinez JF.
Screening teniposide for Y-site physical incompatibilities.
Hosp Pharm 1994 ; 29: 1010-1017.
1026 Časopis Mayron D, Gennaro AR.
Stability and compatibility of topotecan hydrochloride with selected drugs.
Am J Health-Syst Pharm 1999 ; 56: 875-881.
1178 Časopis Benvenuto JA, Anderson RW, Kerkof K, Smith RG, Loo TL.
Stability and compatibility of antitumor agents in glass and plastic containers.
Am J Hosp Pharm 1981 ; 38: 1914-1918.
1239 Časopis Stolk LML, Fruijtier A, Umans .
Stability after freezing and thawing of solutions of mitomycin C in plastic minibags for intravesical use.
Pharm Weekbl [Sci] 1986 ; 8: 286-288.
1410 Časopis Trissel LA, Martinez JF, Simmons M.
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 141-145.
1423 Časopis Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1827 Časopis Beijnen JH, Van Gijn R, Underberg WJM.
Chemical stability of the antitumor mitomycin C in solutions for intravesical instillation.
J Parenter Sci Technol 1990 ; 44: 332-335.
2247 Časopis Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278.
3128 Laboratorija Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit
Prostrakan 2013
3575 Laboratorija Mitomycine (Ametycine®) - Résumé des caractéristiques du produit
Prostrakan 2013
3897 Časopis Briot T, Truffaut C, Le Quay L, Lebreton A, Lagarce F.
Stability of Reconstituted and Diluted Mitomycin C Solutions in Polypropylene Syringes and Glass Vials.
Pharmaceutical Technology in Hospital Pharmacy 2016 ;1,2:83-89
4154 Laboratorija Bleomycin sulfate- Summary of Product Characteristics
Accord Health Care 2018
4282 Časopis Myers A-L, Zhang Y-P, Kawedia J-D, Zhou X,. Sobocinski S-M, Metcalfe M-J, Kramer M-A, Dinney C.P.N, Kamat A-M.
Solubilization and Stability of Mitomycin C Solutions Prepared for Intravesical Administration.
Drugs R D 2017
4367 Časopis Kinast R.M, Akula K.K, DeBarber A.E, Barker G.T, Gardiner S.K, Whitson E, Mansberger S.L.
The Degradation of Mitomycin C Under Various Storage Methods.
J Glaucoma 2016 ; 25, 6: 477-481.
4471 Laboratorija Amétycine 10 mg poudre pour solution injectable - Résumé des caractéristiques du produit - Oct 10, 2019
Kyowa Kirin Pharma 2019
4526 Časopis Nisse, Y.E, Vigneron J, Zenier H, D'Huart E, Demoré B.
Stability of mitomycin in polypropylene syringes for use in glaucoma surgery.
EJOP 2021 4: 1.
4763 Časopis Almasi J, Erdnuss F, Thiesen J, Krämer I.
Physicochemical stability of urea-containing Mitomycin C preparations in glass vials (1.0 mg/mL) and plastic syringes (2.0, 0.4, 0.2 mg/mL)
Pharmaceutical Technology in Hospital Pharmacy 2023 ;8,1

  Mentions Légales